Apr 30, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM
Mar 28, 2026 04:45PM
Oct 20, 2022 09:06AM
Oct 20, 2022 09:05AM AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
Oct 17, 2022 08:30AM
Oct 17, 2022 08:30AM
Aug 24, 2022 08:30AM
Aug 24, 2022 08:30AM
Aug 4, 2022 03:05PM
Aug 4, 2022 08:01AM
Aug 4, 2022 08:00AM AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
May 31, 2022 04:05PM
May 31, 2022 04:05PM
May 31, 2022 08:30AM
May 31, 2022 08:30AM
May 18, 2022 08:30AM
May 18, 2022 08:30AM
May 11, 2022 08:30AM ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS® (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis
May 11, 2022 08:30AM
May 5, 2022 04:05PM
May 5, 2022 04:05PM
Mar 4, 2022 09:00PM
Mar 2, 2022 09:26AM
Mar 1, 2022 06:00PM
Mar 1, 2022 04:05PM ChemoCentryx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
Mar 1, 2022 04:05PM
Jan 19, 2022 08:31AM
Jan 19, 2022 08:30AM
Jan 19, 2022 08:30AM
Nov 12, 2021 08:31AM
Nov 12, 2021 08:30AM
Nov 12, 2021 08:30AM Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP)
Nov 9, 2021 04:05PM
Nov 9, 2021 04:05PM
Nov 4, 2021 08:30AM
Nov 4, 2021 08:30AM
Oct 8, 2021 01:29PM
Oct 8, 2021 01:25PM
Oct 8, 2021 09:26AM Pre-Open Stock Movers 10/08: (CCXI) (SNDL) (MNTV) Higher; (ALLO) (AGRX) (CDTX) Lower (more...)
Oct 8, 2021 07:19AM
Oct 8, 2021 07:00AM
Oct 8, 2021 07:00AM
Oct 8, 2021 07:00AM
Oct 7, 2021 06:00PM
Sep 27, 2021 05:05PM
Sep 27, 2021 08:30AM ChemoCentryx (CCXI) Announces Approval of TAVNEOS in Japan for Treatment of ANCA-Associated Vasculitis
Sep 27, 2021 08:30AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All